A new market study, titled “Periodontal Therapeutics – Global Market Outlook (2017-2023)”, has been featured on WiseGuyReports.
According to research report, the Global Periodontal Therapeutics Market is valued at $259.34 million in 2016 and is expected to reach $511.76 million by 2023 growing at a CAGR of 10.2% from 2016 to 2023. Owing to increasing pool of diabetic patients will raise the Periodontal Therapeutics market growth. In addition, rising prevalence of periodontal disorders and the surging research activities for technological advancements in therapeutics are some factors positively impacting the growth. On the other hand, lack of favourable reimbursement policies in various countries across the world may limit the growth of this market.
By product, systemic antibiotics segment have the largest market share and is expected to remain the same for next few years due to high market penetration by product affordability. Followed by local antibiotics segment expected to grow faster due less chances of formation of resistant bacteria following fewer side effects. North American region has the largest market share in periodontal therapeutics market by increasing healthcare expenditure leading to increased demand for better oral healthcare therapeutics. Asia Pacific region is expected to grow at a higher CAGR during the forecast period owing to its population growth.
Some of the key players in the market include Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited.
Product Type Covered:
- Local Antibiotics
o Other Local Antibiotics
- Systemic Antibiotics
o Other Systemic Antibiotics
Distribution Channel Covered:
- Retail Pharmacies
- Drug Stores
- Hospitals Pharmacies
- North America
o Rest of Europe
- Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Periodontal Therapeutics Market, By Product
6 Global Periodontal Therapeutics Market, By Distribution Channel
7 Global Periodontal Therapeutics Market, By Geography
8 Key Developments
9 Company Profiling
9.1 Fibrocell Sciences, Inc
9.2 Tolmar Inc
9.3 Eli Lilly & Company
9.4 Align Technology Inc.
9.5 Dentsply International
9.7 Ultradent Products Inc.
9.8 Nobel Biocare Holdings AG
9.9 Glidewell Laboratories, Inc.
9.11 Kaken Pharmaceutical
9.12 Valeant Pharmaceuticals Int. Inc
9.13 Den-Mat Holdings
9.14 Mallinckrodt Pharmaceuticals
9.15 Purdue Pharma L.P.
9.16 Teva Pharmaceutical Industries Limited
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)